Opposition doing politics over indigenous Covid vaccine: BJP

The BJP on Friday said all that its rivals, especially the Congress, have contributed to the matter is 'politics and confusion'

Vaccine
Photo: Bloomberg
Press Trust of India New Delhi
2 min read Last Updated : Mar 05 2021 | 8:23 PM IST

Keeping up its attack on the Opposition over the COVID-19 vaccine issue, the BJP on Friday said all that its rivals, especially the Congress, have contributed to the matter is "politics and confusion".

BJP spokesperson Sambit Patra hit out at opposition-ruled states like Chhattisgarh, Punjab and Kerala for "refusing" to use the indigenous Covaxin, developed by Bharat Biotech, and said they are playing with the lives of people for their "petty" politics.

On the other hand Prime Minister Narendra Modi has sent out a big message to the world by getting the Covaxin jab, he told reporters here.

"The politics being played in the opposition-ruled states is an insult to the country's scientists and also hurts the 'aatmanirbhar bharat' sentiments," Patra said.

"I want to ask do you not trust scientists and doctors of your country? Over 40 countries have placed order for Covaxin. But in India, we have people doing politics over it for their selfish political interests," the BJP spokesperson said.

Bharat Biotech's Covaxin vaccine, whose emergency use approval before finishing final stage testing had triggered a row, has shown an 81 per cent efficacy in preventing symptomatic COVID-19 disease in an interim analysis of the advanced clinical trial, the company said on Wednesday, boosting prospects of its usage.

Patra alleged that opposition leaders would tease the government by asking why doesn't Prime Minister Modi prove its efficacy by opting for its jab.

Modi did it when his turn came, by following all protocols, he said, noting that President Ram Nath Kovind and Vice President M Venkaiah Naidu also opted for Covaxin.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Bharatiya Janata PartyOpposition partiesCoronavirus Vaccine

First Published: Mar 05 2021 | 8:19 PM IST

Next Story